MEIS1 and MEIS2 Expression and Prostate Cancer Progression: A Role for HOXB13 Binding Partners in Metastatic Disease

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-17-3673
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

MEIS1 Down-Regulation by MYC Mediates Prostate Cancer Development Through Elevated HOXB13 Expression and AR Activity

2019English

Expression Characteristics of Prostate-Derived Ets Factor Support a Role in Breast and Prostate Cancer Progression

Human Pathology
Forensic MedicinePathology
2007English

Stat3 Promotes Metastatic Progression of Prostate Cancer

American Journal of Pathology
Forensic MedicinePathology
2008English

Prostate Cancer Predisposition Loci and Risk of Metastatic Disease and Prostate Cancer Recurrence

Clinical Cancer Research
Cancer ResearchOncology
2011English

Supporting a Role for the GTPase Rab7 in Prostate Cancer Progression

PLoS ONE
Multidisciplinary
2014English

A Hoxb13-Driven Reverse Tetracycline Transactivator System for Conditional Gene Expression in the Prostate

Prostate
OncologyUrology
2012English

Neutrophils Are Mediators of Metastatic Prostate Cancer Progression in Bone

Cancer Immunology, Immunotherapy
Cancer ResearchMedicineOncologyAllergyImmunology
2020English

Emotional Expression and Psychological Adjustment to Prostate Cancer: A Brief Intervention for Patients and Their Partners

2003English

CCR2 Expression Correlates With Prostate Cancer Progression

Journal of Cellular Biochemistry
BiochemistryCell BiologyMolecular Biology
2007English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy